Gary A. Abrams

3.5k total citations · 1 hit paper
31 papers, 1.7k citations indexed

About

Gary A. Abrams is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Gary A. Abrams has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 14 papers in Hepatology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Gary A. Abrams's work include Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (8 papers) and Diet, Metabolism, and Disease (6 papers). Gary A. Abrams is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (8 papers) and Diet, Metabolism, and Disease (6 papers). Gary A. Abrams collaborates with scholars based in United States, Brazil and United Kingdom. Gary A. Abrams's co-authors include Ronald H. Clements, Audrey J. Lazenby, Sachin Kunde, Sudheer K. Mantena, Heather B. Eccleston, Kelly K. Andringa, Shannon M. Bailey, Adrienne L. King, Michael B. Fallon and Bao Luo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Gary A. Abrams

28 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial

2023 146 citations Stephen A. Harrison, Juan P. Frías et al. The Lancet. Gastroenterology & hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary A. Abrams United States	17	1.2k	558	444	343	311	31	1.7k
Ibrahim Mostafa Egypt	13	1.3k 1.0×	470 0.8×	633 1.4×	207 0.6×	449 1.4×	28	1.9k
Natsu Fukui United States	8	1.6k 1.2×	843 1.5×	529 1.2×	267 0.8×	295 0.9×	19	1.9k
Bienvenido Gra‐Oramas Cuba	5	1.7k 1.3×	912 1.6×	642 1.4×	248 0.7×	316 1.0×	5	1.8k
Münevver Demir Germany	24	1.5k 1.2×	619 1.1×	654 1.5×	221 0.6×	317 1.0×	95	2.3k
Dante Romagnoli Italy	14	1.6k 1.3×	820 1.5×	616 1.4×	308 0.9×	257 0.8×	25	1.8k
Elnaz Ehteshami Afshar Canada	6	1.2k 0.9×	456 0.8×	371 0.8×	152 0.4×	272 0.9×	10	1.5k
Sae Kyung Joo South Korea	22	1.4k 1.1×	538 1.0×	480 1.1×	139 0.4×	210 0.7×	61	1.9k
F. Pons‐Romero Spain	21	1.6k 1.3×	369 0.7×	934 2.1×	326 1.0×	346 1.1×	61	2.1k
Thomas G. Cotter United States	18	1.2k 1.0×	349 0.6×	672 1.5×	224 0.7×	381 1.2×	55	1.7k
David Ka‐Wai Yeung Hong Kong	19	2.1k 1.7×	933 1.7×	733 1.7×	347 1.0×	385 1.2×	21	2.6k

Countries citing papers authored by Gary A. Abrams

Since Specialization

Citations

This map shows the geographic impact of Gary A. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Abrams more than expected).

Fields of papers citing papers by Gary A. Abrams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Abrams. The network helps show where Gary A. Abrams may publish in the future.

Co-authorship network of co-authors of Gary A. Abrams

This figure shows the co-authorship network connecting the top 25 collaborators of Gary A. Abrams. A scholar is included among the top collaborators of Gary A. Abrams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary A. Abrams. Gary A. Abrams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abrams, Gary A., et al.. (2025). FibroScan Discordance With Liver Biopsy Significantly Overestimates Advanced Fibrosis and Cirrhosis in MASLD Subjects With Class 3 Obesity. Journal of Clinical Gastroenterology. 60(2). 175–181. 2 indexed citations

Abrams, Gary A., et al.. (2024). VCTE Overestimates Liver Fibrosis due to Abdominal–Truncal Adiposity and Not Hepatic Steatosis: A Case Report. SHILAP Revista de lepidopterología. 2024(1). 7938701–7938701. 1 indexed citations

Harrison, Stephen A., Juan P. Frías, Guy Neff, et al.. (2023). Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. The Lancet. Gastroenterology & hepatology. 8(12). 1080–1093. 146 indexed citations breakdown →

Hecht, Eric M., Eurídice Martínez Steele, Gary A. Abrams, et al.. (2022). Cross-sectional examination of ultra-processed food consumption and adverse mental health symptoms. Public Health Nutrition. 25(11). 3225–3234. 33 indexed citations

Abrams, Gary A., et al.. (2022). Accuracy of intravitreal injection volume for aflibercept pre-filled syringe and BD Luer-Lok one-milliliter syringe. International Journal of Retina and Vitreous. 8(1). 27–27. 16 indexed citations

Abrams, Gary A., et al.. (2021). Serum Alanine Transaminase Is an Inadequate Nonalcoholic Fatty Liver Screening Test in Adolescents: Results From the National Health and Nutrition Examination Survey 2017-2018. Clinical Pediatrics. 60(8). 370–375. 6 indexed citations

Hendrie, Jonathan D., et al.. (2021). Two Fatty Liver Conditions Masquerading as Autoimmune Hepatitis. SHILAP Revista de lepidopterología. 2021. 1–5.

Hecht, Eric M., et al.. (2020). Healthy Behavior Adherence: The National Health and Nutrition Examination Survey, 2005–2016. American Journal of Preventive Medicine. 59(2). 270–273. 16 indexed citations

Abrams, Gary A., et al.. (2016). LOGIQ E9 Shear Wave Elastrography for Detection of Liver Fibrosis in Patients with Chronic Hepatitis C Virus. Southern Medical Journal. 109(11). 730–734. 5 indexed citations

10.

Eccleston, Heather B., Kelly K. Andringa, Angela M. Betancourt, et al.. (2010). Chronic Exposure to a High-Fat Diet Induces Hepatic Steatosis, Impairs Nitric Oxide Bioavailability, and Modifies the Mitochondrial Proteome in Mice. Antioxidants and Redox Signaling. 15(2). 447–459. 103 indexed citations

11.

Qureshi, Kamran, Ronald H. Clements, Fahad Saeed, & Gary A. Abrams. (2010). Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease. Journal of Obesity. 2010. 1–7. 23 indexed citations

12.

Qureshi, Kamran, Ronald H. Clements, & Gary A. Abrams. (2008). The Utility of the “NAFLD Fibrosis Score” in Morbidly Obese Subjects with NAFLD. Obesity Surgery. 18(3). 264–270. 46 indexed citations

13.

Yang, Yingkui, Min Chen, Ronald H. Clements, et al.. (2008). Human Mesenteric Adipose Tissue Plays Unique Role Versus Subcutaneous and Omental Fat in Obesity Related Diabetes. Cellular Physiology and Biochemistry. 22(5-6). 531–538. 85 indexed citations

14.

Boetticher, Nicholas C., Craig J. Peine, Paul Y. Kwo, et al.. (2008). A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis. Gastroenterology. 135(6). 1953–1960. 237 indexed citations

15.

Lazenby, Audrey J., et al.. (2007). Influence of Liver Biopsy Heterogeneity and Diagnosis of Nonalcoholic Steatohepatitis in Subjects Undergoing Gastric Bypass. Obesity Surgery. 17(2). 155–161. 61 indexed citations

16.

Liu, Xiuli, Audrey J. Lazenby, Ronald H. Clements, Nirag Jhala, & Gary A. Abrams. (2007). Resolution of Nonalcoholic Steatohepatits after Gastric Bypass Surgery. Obesity Surgery. 17(4). 486–492. 109 indexed citations

17.

Clements, Ronald H., et al.. (2006). The Prevalence of Nonalcoholic Steatohepatitis is Greater in Morbidly Obese Men Compared to Women. Obesity Surgery. 16(10). 1351–1358. 52 indexed citations

18.

Abrams, Gary A., Sachin Kunde, Audrey J. Lazenby, & Ronald H. Clements. (2004). Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Hepatology. 40(2). 475–483. 147 indexed citations

19.

Hidalgo, José A., George Alangaden, Dean Eliott, et al.. (2000). Fungal Endophthalmitis Diagnosis by Detection ofCandida albicansDNA in Intraocular Fluid by Use of a Species‐Specific Polymerase Chain Reaction Assay. The Journal of Infectious Diseases. 181(3). 1198–1201. 41 indexed citations

20.

Luo, Bao, Gary A. Abrams, & Michael B. Fallon. (1998). Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. Journal of Hepatology. 29(4). 571–578. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact